Zusammenfassung

• Objekte (1 geändert, 0 hinzugefügt, 0 gelöscht)
  • Wikiderm.EntryClass[0]

Details

Wikiderm.EntryClass[0]

Eintrag

...	...	@@ -59,13 +59,19 @@
59	59	(% class="Bullet" %)-(%%) Pyoderma gangraenosum
60	60
61	61	(% class="Eintrag-2" %)
62		-(% class="Feature" %)TF:(%%) Infekte
	62	+(% class="Feature" %)TF:(%%) (% class="Bullet" %)-(%%) Infekte
63	63
64	64	(% class="Ebene-2" %)
65	65	(% class="Feature" %)Bsp:(%%) Mycoplasma pneumoniae, HIV
66	66
	67	+(% class="Ebene-1" %)
	68	+(% class="Bullet" %)-(%%) Dupilumab
	69	+
	70	+(% class="Ebene-2" %)
	71	+(% class="Feature" %)Lit:(%%) Australas J Dermatol. 2023 Nov 27. [[http:~~/~~/doi.org/10.1111/ajd.14190>>url:http://doi.org/10.1111/ajd.14190]]
	72	+
67	67	(% class="Eintrag-2" %)
68		-(% class="Feature" %)DD:(%%) (% class="Bullet" %)-(%%) (% class="Abbreviation" %)AGEP(%%)
	74	+(% class="Feature" %)DD:(%%) (% class="Bullet" %)-(%%) AGEP
69	69
70	70	(% class="Ebene-1" %)
71	71	(% class="Bullet" %)-(%%) Dermatitis herpetiformis
...	...	@@ -128,7 +128,7 @@
128	128	(% class="Feature" %)Lit:(%%) J Dermatol 2000; 27: 669-72
129	129
130	130	(% class="Ebene-3" %)
131		-(% class="Feature" %)PT:(%%) (% class="Abbreviation" %)CR(%%)
	137	+(% class="Feature" %)PT:(%%) CR
132	132
133	133	(% class="Ebene-3" %)
134	134	(% class="Feature" %)Altn:(%%) Maxacalcitol
...	...	@@ -137,7 +137,7 @@
137	137	(% class="Feature" %)Lit:(%%) Clin Exp Dermatol. 2015 May 19. [[http:~~/~~/doi.org/10.1111/ced.12680>>url:http://doi.org/10.1111/ced.12680]]
138	138
139	139	(% class="Ebene-5" %)
140		-(% class="Feature" %)Lit:(%%) (% class="Abbreviation" %)CR(%%)
	146	+(% class="Feature" %)Lit:(%%) CR
141	141
142	142	(% class="Ebene-2" %)
143	143	(% class="Bullet" %)-(%%) Dapson Gel
...	...	@@ -152,7 +152,7 @@
152	152	(% class="Bullet" %)-(%%) Dapson
153	153
154	154	(% class="Ebene-3" %)
155		-(% class="Feature" %)Bed:(%%) (% class="Abbreviation" %)GS(%%)
	161	+(% class="Feature" %)Bed:(%%) GS
156	156
157	157	(% class="Ebene-3" %)
158	158	(% class="Feature" %)Dos:(%%) 100-150 mg/Tag
...	...	@@ -191,8 +191,11 @@
191	191	(% class="Bullet" %)-(%%) Apremilast
192	192
193	193	(% class="Ebene-3" %)
194		-(% class="Feature" %)Lit:(%%) Australas J Dermatol. 2020 Feb 11. [[http:~~/~~/doi.org/10.1111/ajd.13253>>url:http://doi.org/10.1111/ajd.13253]]
	200	+(% class="Feature" %)Lit:(%%) (% class="Bullet" %)-(%%) Australas J Dermatol. 2020 Feb 11. [[http:~~/~~/doi.org/10.1111/ajd.13253>>url:http://doi.org/10.1111/ajd.13253]]
195	195
	202	+(% class="Ebene-3" %)
	203	+(% class="Bullet" %)-(%%) Australas J Dermatol. 2023 Aug;64(3):e310-e312. [[http:~~/~~/doi.org/10.1111/ajd.14073>>url:http://doi.org/10.1111/ajd.14073]]
	204	+
196	196	(% class="Ebene-2" %)
197	197	(% class="Bullet" %)-(%%) Anti-TNF-alpha
198	198
...	...	@@ -209,7 +209,7 @@
209	209	(% class="Feature" %)Lit:(%%) Ann Dermatol Venereol. 2013 Dec;140(12):797-800 (Frankreich)
210	210
211	211	(% class="Ebene-5" %)
212		-(% class="Feature" %)PT:(%%) (% class="Abbreviation" %)CR(%%)
	221	+(% class="Feature" %)PT:(%%) CR
213	213
214	214	(% class="Ebene-2" %)
215	215	(% class="Bullet" %)-(%%) Guselkumab